Author Archives: Ed Wild

Reading list for masters students, 2019

Byrne et al 2018

Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease
Science Translational Medicine 2018

Byrne et al 2017

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington’s disease: a retrospective cohort analysis. Lancet Neurology 2017

Wild & Tabrizi 2017

Therapies targeting DNA and RNA in Huntington’s disease. Lancet Neurology 2017
Overview of huntingtin-lowering therapies in development.

Bates et al 2015

Huntington Disease. Nat Rev Disease Primers. 2015: 15005
Overview of HD biology, clinical features and therapeutic landscape

G Bates (textbook)

Huntington’s Disease (Oxford Monographs on Medical Genetics), 3rd ed. Ed G Bates, L Jones & S Tabrizi. Oxford University Press. ISBN 978-0199929146
Comprehensive monograph on HD

Wild & Tabrizi 2014

Targets for future clinical trials in Huntington’s disease: What’s in the pipeline? Mov Disord. 2014 Sep 15;29(11):1434-45. PMID: 25155142.
Therapeutic overview

Reading list for Masters Students 2018

Johnson et al 2018

Neurofilament light protein in blood predicts regional atrophy in Huntington disease. Neurology 2018

Byrne et al 2017

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington’s disease: a retrospective cohort analysis. Lancet Neurology 2017

Wild & Tabrizi 2017

Therapies targeting DNA and RNA in Huntington’s disease. Lancet Neurology 2017
Overview of huntingtin-lowering therapies in development.

Bates et al 2015

Huntington Disease. Nat Rev Disease Primers. 2015: 15005
Overview of HD biology, clinical features and therapeutic landscape

G Bates (textbook)

Huntington’s Disease (Oxford Monographs on Medical Genetics), 3rd ed. Ed G Bates, L Jones & S Tabrizi. Oxford University Press. ISBN 978-0199929146
Comprehensive monograph on HD

 

Wild & Tabrizi 2014

Targets for future clinical trials in Huntington’s disease: What’s in the pipeline? Mov Disord. 2014 Sep 15;29(11):1434-45. PMID: 25155142.
Therapeutic overview